
Hubei Biocause Pharmaceutical Co., Ltd.
SZSE:000627.SZ
Overview | Financials
Company Name | Hubei Biocause Pharmaceutical Co., Ltd. |
Symbol | 000627.SZ |
Currency | CNY |
Price | 3.1 |
Market Cap | 15,315,953,050 |
Dividend Yield | 4.74% |
52-week-range | 2.79 - 3.91 |
Industry | Insurance—Life |
Sector | Financial Services |
CEO | Ms. Wenxia Zhou |
Website | https://www.biocause.com |
An error occurred while fetching data.
About Hubei Biocause Pharmaceutical Co., Ltd.
Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. The company also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, it is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD